Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • yaximik
    Senior Member
    • Apr 2011
    • 199

    GPU vs Phi: advice needed

    A while ago I asked a general question about practical usability of GPU- and Phi- based platforms for multithread-enabled bioinformatics applications. I am aware of previously held discussion here. My understanding that there was not much experience accumulated yet with use of these systems to outline the differences in capabilities. I wonder if there is more of such experience now. Basically I have choice to obtain a RHEL 6 server equipped with 2 8-core Xeon E5 2690 and 4 either K20x GPU or 60-core Xeon Phi coprocessors. The price is about the same. Microway engineers advise to go with GPU as there are more applications developed.
    As I am not programmer, rather a self-educating end user, my question is which configuration will be more usable in the current universe of bioinformatis applications without code modifications? Please forgive if my questions sound naive. For example, very likely I will not be able to take advantage of thousands of cores with the GPU configuration when using GNU parallel or multithreading in BWA or blast+ without significant investment in code modification. But what about Phi - can I take immediate advantage of 240 cores with the Phi configuration?
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    We had a recent discussion on this with input from Rick Westerman: http://seqanswers.com/forums/showthread.php?t=20931

    I/O and memory needs of most NGS applications make use of either the GPU/Phi impractical at this time. Unless you have a use case identified for either the GPU/Phi, you may be better off putting that money towards upgrade of some other components.
    Last edited by GenoMax; 09-11-2013, 06:47 AM.

    Comment

    • ymc
      Senior Member
      • Mar 2010
      • 496

      #3
      While GPU-based NGS applications are not that many, Phi-based NGS applications are basically nil (Let me know if you know of one). soap3-dp is a GPU-based application that you can use to replace bwa.

      I think you will only pick Phi if you have some floating point application that is based on some old code optimized for x86. There aren't many such application for NGS. Therefore it makes no sense to use Phi at all.

      Comment

      • ymc
        Senior Member
        • Mar 2010
        • 496

        #4
        Originally posted by GenoMax View Post
        We had a recent discussion on this with input from Rick Westerman: http://seqanswers.com/forums/showthread.php?t=20931

        I/O and memory needs of most NGS applications make use of either the GPU/Phi impractical at this time. Unless you have a use case identified for either the GPU/Phi, you may be better off putting that money towards upgrade of some other components.
        If you have some application that make use of floating point calculations a lot, then the value of GPU will show. For example, I have a CUDA program that calculates pairwise familial relationships between my samples.

        Another way of thinking is that using GPU can make your system more compact. For example, you can run soap3-dp on a GPU and then do other stuff with your CPUs. In this sense, your computations per one computer case volume will be higher than without GPU.

        Comment

        • yaximik
          Senior Member
          • Apr 2011
          • 199

          #5
          I missed the most recent discussion, thanks for the link, very useful. Also thanks a lot for other useful inputs.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          19 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          18 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          25 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          38 views
          0 reactions
          Last Post SEQadmin2  
          Working...